162 related articles for article (PubMed ID: 17852559)
1. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
Hodkinson PS; Mackinnon AC; Sethi T
Int J Radiat Biol; 2007; 83(11-12):733-41. PubMed ID: 17852559
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
Rintoul RC; Sethi T
Clin Sci (Lond); 2002 Apr; 102(4):417-24. PubMed ID: 11914104
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
[TBL] [Abstract][Full Text] [Related]
5. Small cell lung cancer: the importance of the extracellular matrix.
Buttery RC; Rintoul RC; Sethi T
Int J Biochem Cell Biol; 2004 Jul; 36(7):1154-60. PubMed ID: 15109562
[TBL] [Abstract][Full Text] [Related]
6. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
Hartmann TN; Burger M; Burger JA
J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
[TBL] [Abstract][Full Text] [Related]
7. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase.
Hodkinson PS; Elliott T; Wong WS; Rintoul RC; Mackinnon AC; Haslett C; Sethi T
Cell Death Differ; 2006 Oct; 13(10):1776-88. PubMed ID: 16410797
[TBL] [Abstract][Full Text] [Related]
8. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
Kraus AC; Ferber I; Bachmann SO; Specht H; Wimmel A; Gross MW; Schlegel J; Suske G; Schuermann M
Oncogene; 2002 Dec; 21(57):8683-95. PubMed ID: 12483521
[TBL] [Abstract][Full Text] [Related]
9. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
Elliott T; Sethi T
Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
[TBL] [Abstract][Full Text] [Related]
10. Effects of collagen iv on cisplatin-induced apoptosis of non-small cell lung cancer cells.
Su C; Su B; Tang L; Zhao Y; Zhou C
Cancer Invest; 2007; 25(7):542-9. PubMed ID: 17952737
[TBL] [Abstract][Full Text] [Related]
11. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
12. The role of extracellular matrix in small-cell lung cancer.
Rintoul RC; Sethi T
Lancet Oncol; 2001 Jul; 2(7):437-42. PubMed ID: 11905738
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
[TBL] [Abstract][Full Text] [Related]
14. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and lung cancer: a review.
Shivapurkar N; Reddy J; Chaudhary PM; Gazdar AF
J Cell Biochem; 2003 Apr; 88(5):885-98. PubMed ID: 12616528
[TBL] [Abstract][Full Text] [Related]
17. Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury.
Cordes N
Cancer Lett; 2006 Oct; 242(1):11-9. PubMed ID: 16448744
[TBL] [Abstract][Full Text] [Related]
18. Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells.
Fu ZY; Han JX; Huang HY
Chin Med J (Engl); 2007 Oct; 120(19):1710-5. PubMed ID: 17935676
[TBL] [Abstract][Full Text] [Related]
19. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
20. The integrin-extracellular matrix axis in pancreatic cancer.
Grzesiak JJ; Ho JC; Moossa AR; Bouvet M
Pancreas; 2007 Nov; 35(4):293-301. PubMed ID: 18090233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
